While epigenetic therapy emerges as a new strategy to overcome drug resistance and re-sensitize cancer cells to chemotherapy [22, 23], we wondered whether entinostat might possess such activity as a chemo-sensitizer via inhibition of Survivin. Here, BIRC5 is linked to cancer.